Almac

United Kingdom
Small Molecule API Oral Solid Dose Packaging & Labeling
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (4) ○ Clinical Trials ○ SEC Filings ✓ Press (11) ✓ EMA GMP (3) ✓ MHRA GMP (12) ✓ HC GMP (17)

Quick Facts: Almac

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
United Kingdom
Website
Modalities
Small Molecule API, Oral Solid Dose, Packaging & Labeling
Active Programs
No ClinicalTrials.gov matches confirmed — 1 partnership signal in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Almac

Almac is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Oral Solid Dose, Packaging & Labeling. 3 manufacturing sites registered with the U.S. FDA, the UK MHRA and Health Canada. Website: https://www.almacgroup.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Almac FDA Inspection History

2025-11
2025-08
2025-05
2024-09
NAI VAI OAI
Date Site Type Observations Classification
2025-11-28
Almac Pharma Services Limited
Craigavon Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2025-08-22
Almac Pharma Services LLC
Audubon, Pennsylvania Company-level
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2025-05-08
Almac Sciences Limited
Craigavon Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2024-09-16
Almac Pharma Services Limited
Craigavon Company-level
Drug Quality Assurance No Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Almac FDA 483 Findings 9 observations · 2025-08-22 → 2025-11-28 ?

By subsystem

  • Documentation & Records 4 (44.4%)
  • CAPA 2 (22.2%)
  • Other 1 (11.1%)
  • Equipment & Facilities 1 (11.1%)
  • Data Integrity 1 (11.1%)

By severity

  • 5 — Critical: 1
  • 3 — Moderate: 2
  • 2 — Minor: 6
  • Repeat observations: 0

Most severe findings

  • Critical (5) Data Integrity 2025-11-28 21 CFR 211.68(b)
    Computer control of master formula records

    "Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."

  • Moderate (3) CAPA 2025-11-28 21 CFR 211.192
    Investigations of discrepancies, failures

    "There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed."

  • Moderate (3) CAPA 2025-08-22 21 CFR 211.192
    Investigations of discrepancies, failures

    "There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed."

Almac EMA GMP Compliance 3 certificates

2019-11
2019-10
2019-03
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
UK MIA(IMP) 20782 Insp GMP/GDP/IMP 20782/15328-0017 ALMAC PHARMA SERVICES LIMITED United Kingdom (Northern Ireland) 2019-11-18 COMPLIANT
UK GMP 31890 Insp GMP/IMP 31890/16997281-0004 [V] ALMAC SCIENCES LIMITED United Kingdom (Northern Ireland) 2019-10-10 COMPLIANT
UK MIA(IMP) 31890 Insp GMP/IMP 31890/383321-0012 ALMAC SCIENCES LIMITED United Kingdom (Northern Ireland) 2019-03-21 COMPLIANT
Source: EMA EudraGMDP · Retrieved Oct 31, 2026

Almac MHRA GMP Compliance 12 certificates

2025-09
2025-09
2025-05
2025-05
2025-05
2025-02
2024-09
2024-09
2019-12
2019-12
2019-12
2009-05
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK MIA 20782 Insp GMP/IMP 20782/17799871-0011[H] ALMAC PHARMA SERVICES LIMITED LOUGHBOROUGH LE11 5RB 2025-09-29 COMPLIANT
UK MIA(IMP) 20782 Insp GMP/IMP 20782/17799871-0011[I] ALMAC PHARMA SERVICES LIMITED LOUGHBOROUGH LE11 5RB 2025-09-29 COMPLIANT
UK API 31890 Insp GMP 31890/383321-0022 ALMAC SCIENCES LIMITED CRAIGAVON BT63 5QD 2025-05-07 COMPLIANT
UK GMP 31890 Insp GMP/IMP 31890/16997281-0010 [H] ALMAC SCIENCES LIMITED CRAIGAVON BT63 5XA 2025-05-07 COMPLIANT
UK GMP 31890 Insp GMP/IMP 31890/16997281-0010 [V] ALMAC SCIENCES LIMITED CRAIGAVON BT63 5XA 2025-05-07 COMPLIANT
UK MIA(IMP) 31890 Insp IMP 31890/16997281-0005[I] ALMAC SCIENCES LIMITED CRAIGAVON BT63 5XA 2025-02-06 COMPLIANT
UK MIA 20782 Insp GMP 20782/15328-0020[H] ALMAC PHARMA SERVICES LIMITED CRAIGAVON BT63 5UA 2024-09-16 COMPLIANT
UK MIA(IMP) 20782 Insp GMP/GDP/IMP 20782/15328-0018[I] ALMAC PHARMA SERVICES LIMITED CRAIGAVON BT63 5UA 2024-09-16 COMPLIANT
UK API 31890 Insp GMP 31890/383321-0016 ALMAC SCIENCES LIMITED CRAIGAVON BT63 5QD 2019-12-16 COMPLIANT
UK API 31890 Insp GMP/GDP 31890/383321-0015 [H] ALMAC SCIENCES LIMITED CRAIGAVON BT63 5QD 2019-12-16 COMPLIANT
UK API 31890 Insp GMP/GDP 31890/383321-0015 [V] ALMAC SCIENCES LIMITED CRAIGAVON BT63 5QD 2019-12-16 COMPLIANT
UK API 31890 Insp GMP 31890/383321-0001 ALMAC SCIENCES LIMITED CRAIGAVON BT63 5QD 2009-05-21 COMPLIANT
Source: MHRA GMDP Database · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 11 articles

Company announcements, not verified evidence. They do not change any score.
partnership 2026-10-08
CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan - Manufacturing Chemist
CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan  Manufacturing Chemist
news Wed, 29 Ma
As many CDMOs battle post-pandemic sales downturn, Almac's revenue jumps amid global expansion push - Fierce Pharma
news Wed, 10 Ap
Newsmakers Q&A: Almac Group - Contract Pharma
news Wed, 06 Ma
Growing Almac boosts capacity for manufacturing peptides and packaging commercial products - Fierce Pharma
news Tue, 14 Oc
Almac makes $48M commitment to eClinical offering with new trial coordinator platform - Fierce Biotech
news Tue, 11 Ma
CDMO Almac continues expansion spree with new £65M UK oral treatment plant - Fierce Pharma
news Thu, 20 Ju
Almac Group Unveils Latest GMP Facility - Pharmaceutical Commerce
news Thu, 07 Ma
Almac Group Grows Northern Ireland HQ, Welcomes New Facilities - Pharmaceutical Commerce
news Thu, 02 No
CDMO Almac continues its expansion momentum with lab deal - Fierce Pharma
news Mon, 14 Ma
Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products - newswire.com
news Fri, 18 Ja
Almac Group extends personalised cancer vaccine production facilities - Express Pharma

Frequently Asked Questions About Almac

How many FDA inspections does Almac have on record?
CDMO Signal tracks 4 FDA inspections for Almac, sourced from the FDA inspection database. See the full inspection history above.
Has Almac received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Almac.
Does Almac hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA and 12 MHRA GMP certificates for Almac.
Does Almac have a CDMO Signal Score?
Not yet. Almac is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Almac for a manufacturing program?
Use the free AI matchmaker to compare Almac against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Pierre Fabre CDMO
Castres, France
Oral Solid Dose, Finished Dosage Forms, Non-sterile Liquids, Semi-solids & Liquids, Small Molecule API, High-Potency APIs, Packaging & Labeling
Shionogi Pharma
Settsu, Osaka, Japan
Small Molecule API, High-Potency APIs, Oral Solid Dose, Packaging & Labeling, Clinical Trial Manufacturing
Zhejiang Huahai Pharmaceutical
Linhai, Zhejiang, China
Small Molecule API, Intermediates, Oral Solid Dose, Lyophilization, Packaging & Labeling
Mikart
Atlanta, Georgia, United States
Oral Solid Dose, Oral Liquids, Controlled Substances, Packaging & Labeling
Alcami Carolinas
United States
Oral Solid Dose, Sterile Fill-Finish, Small Molecule API

Compare Almac with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Almac
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.